Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-Wide Association Study of Schizophrenia

ABSTRACT:

The goal of the study is to find susceptibility genes for schizophrenia.

Dataset versioning

Version 1: European-American (EA) ancestry only
Version 2: Version 1 plus African-American (AA) ancestry

Consent groups and participant set

General research use (GRU): 4591 cases and controls (1217 EA cases, 1442 EA controls, 953 AA cases, 979 AA controls)
This consent group includes a subset of schizophrenia cases and all controls (which overlap with Bipolar study controls in Bipolar: GRU dataset).
Schizophrenia and related disorders (SARC): 475 cases (187 EA cases, 288 AA cases)
This consent group includes a subset of schizophrenia cases.

PROVIDER: phs000021 | dbGaP |

SECONDARY ACCESSION(S): PRJNA75799PRJNA75797

REPOSITORIES: dbGaP

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	README.txt	Txt
	phs000021.GAIN_Schizophrenia.analysis-NCBI.tar.gz	Other
	phs000021.pha002857.txt.gz	Txt
	phs000021.pha002859.txt.gz	Txt
	00readme.txt	Txt

Items per page:

1 - 5 of 132

Similar Datasets

Genome-Wide Association Study of Schizophrenia

Project description:The goal of the study is to find susceptibility genes for schizophrenia. Dataset versioning <ul> <li>Version 1: European-American (EA) ancestry only</li> <li>Version 2: Version 1 plus African-American (AA) ancestry</li> </ul> Consent groups and participant set <ul> <li>General research use (GRU): 4591 cases and controls (1217 EA cases, 1442 EA controls, 953 AA cases, 979 AA controls) This consent group includes a subset of schizophrenia cases and all controls (which overlap with Bipolar study controls in Bipolar: GRU dataset).</li> <li>Schizophrenia and related disorders (SARC): 475 cases (187 EA cases, 288 AA cases) This consent group includes a subset of schizophrenia cases.</li> </ul>

| phs000021.v3.p2 | EGA

Whole Genome Association Study of Bipolar Disorder

Project description:The goal of the project is to identify genes that make individuals more susceptible to bipolar disorder (manic depressive illness) and to better understand the brain pathways involved in the disease. Dataset versioning <ul> <li>Version 1: European-American (EA) ancestry only</li> <li>Version 2: Version 1 plus African-American (AA) ancestry</li> <li>Version 3: EA and AA samples plus updated diagnostic criteria</li> </ul> Consent groups and participant set <ul> <li>General research use (GRU): 1767 controls (1081 EA controls, 686 AA controls) This consent group includes all controls for the Bipolar study, which are a subset of controls for the Schizophrenia study (subset of Schizophrenia: GRU).</li> <li>Bipolar and related disorders (BARD): 841 cases (691 EA cases, 150 AA cases) This consent group includes a subset of the Bipolar cases.</li> <li>Bipolar disorder only (BDO): 653 cases (388 EA cases, 265 AA cases) This consent group includes a subset of the Bipolar cases.</li> </ul>

| phs000017.v3.p1 | EGA

Whole Genome Association Study of Bipolar Disorder

| phs000017 | dbGaP

Effect of dietary oils on hippocampus and liver gene expression

Project description:Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. <LI>Brain:</LI> GSM2558: Control GSM2559: Control GSM2560: Fungal oil (AA) GSM2561: Fungal oil (AA) GSM2562: Fish oil (DHA) GSM2563: Fish oil (DHA) GSM2564: Fish and Fungal oil (DHA + AA) <LI>Liver:</LI> GSM2565: Control GSM2566: Control GSM2567: Control GSM2568: Control GSM2569: Fungal oil (AA) GSM2570: Fungal oil (AA) GSM2571: Fish oil (DHA) GSM2572: Fish oil (DHA) GSM2573: Fish + Fungal oil (DHA +AA) GSM2574: Fish + Fungal oil (DHA +AA) Keywords: ordered

2002-11-11 | GSE91 | GEO

Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS nonGAIN)

Project description:This study is part of the Molecular Genetics of Schizophrenia (MGS) genome wide association study (GWAS) of 3,972 cases (2,686 EA and 1,286 AA) and 3,629 controls (2,656 EA and 973 AA) (analyzed sample remaining after quality control exclusions), comprised of European ancestry (EA) and African American (AA) samples. We genotyped about half of the EA sample and almost all of the AA sample under the auspices of the Genetic Association Information Network (GAIN) with the Affymetrix 6.0 platform at the Broad Institute. The remainder of the included sample was also genotyped with the Affymetrix 6.0 platform at the Broad Institute, and we refer to this component as the nonGAIN sample. Cases met criteria for schizophrenia (SCZ) or schizoaffective disorder (SA) per the Diagnostic and Statistical Manual of Mental Disorders version IV (DSM-IV) for all three collections (SGI, MGS1, and MGS2) comprising these cases. However, for the older SGI collection, codes for the secondary diagnoses refer to the older DSM-III-R version. Controls were screened briefly and excluded if they endorsed a history of these illnesses.

| phs000167.v1.p1 | EGA

Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)

| phs000167 | dbGaP

Major Depression: Stage 1 Genomewide Association in Population-Based Samples

Project description:Identification of genomic regions that confer susceptibility to or protection from major depressive disorder (MDD) via genomewide association. Consent groups and participant set <ul> <li>Psychiatric and Related Somatic Conditions (PRSC): 3741 (1821 cases, 1822 controls, 98 others)</li> </ul>

| phs000020.v2.p1 | EGA

Transcriptomic Analysis of Classical Monocytes from African American Patients with Systemic Sclerosis

Project description:Systemic sclerosis is a multisystem autoimmune disorder that has an unclear etiology and disproportionately affects African Americans (AA). Additionally, monocytes show heightened activation in SSc, and in AA relative to European ancestry (EA) individuals. Monocytes are thus a good target tissue for elucidating disease mechanisms. In this study, we sought to identify differentially expressed genes in classical monocytes from AA SSc patients relative to unaffected AA controls. We performed RNAseq to profile the transcriptome on FACS-isolated classical monocytes (CD14++CD16-) from 16 female AA SSc cases and 18 female AA controls. We observed modest gene expression differences between cases and controls. The genes harboring the top differentially methylated cytosines are enriched for metabolic processes. The relatively modest differences in gene expression observed between patients and controls is consistent with prior evidence of stronger inflammatory signatures in AA.

2022-02-07 | GSE196070 | GEO

DNA Methylation Analysis in Classical Monocytes from African American Patients with Systemic Sclerosis

Project description:Systemic sclerosis is a multisystem autoimmune disorder that has an unclear etiology and disproportionately affects African Americans (AA). Additionally, monocytes show heightened activation in SSc, and in AA relative to European ancestry (EA) individuals. Monocytes are thus a good target tissue for elucidating disease mechanisms. In this study, we sought to investigate differentially methylated loci in classical monocytes from AA SSc patients and unaffected AA controls. We used Illumina’s MethylationEPIC BeadChip to profile DNA methylation patterns on FACS-isolated classical monocytes (CD14++CD16-) from 12 female AA SSc cases and 12 female AA controls. We observed modest DNA methylation differences between cases and controls. The genes harboring the top differentially methylated cytosines are enriched for immune pathways and metabolic processes. The relatively modest differences in DNA methylation observed between patients and controls is consistent with prior evidence of stronger inflammatory signatures in AA.

2022-02-07 | GSE196007 | GEO

Collaborative Association Study of Psoriasis

Project description:The goal of this collaborative study is to combine the resources and expertise of three groups with long-standing studies of psoriasis genetics in order to identify new genetic susceptibility factors for psoriasis, a common inflammatory skin disease that affects over 4 million Americans. Consent groups and participant set <ul> <li>General research use (GRU): 1677 (950 cases, 692 controls, 35 others)</li> <li>Autoimmune disease (AD): 1198 (449 cases, 734 controls, 15 others)</li> </ul>

| phs000019.v1.p1 | EGA